Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0012 | 1 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.00035 | 1 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00035 | 1 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |